Brazilian firm Machado, Meyer, Sendacz e Opice Advogados and US firm
Skadden, Arps, Slate, Meagher & Flom LLP have helped one of Brazil’s
largest pharmacy chains, Brazil Pharma, raise US$273.6 million through a
follow-on share offering on the local market.
The issuance was comprised of a primary offering of 45 million common shares
issued by the BTG Pactual subsidiary, with a secondary offering of 7 million
common shares sold by the selling shareholders and an additional 7.8 million
issued by Brazil Pharma.
Machado Meyer previously advised Brazil Pharma on an investment
agreement with its subsidiary - pharmaceutical retail chain Big Benn which was
advised by Pinheiro Guimarães - Advogados - in
February, while last year Skadden Arps teamed up with Mattos Filho to help the company debut on Brazil′s stock
exchange.
Counsel to Brazil Pharma and the selling shareholders
In-house counsel to Brazil Pharma –Cristina Caiuby Salles and Marjorie
Manfredini
Brazil
Machado, Meyer, Sendacz e Opice Advogados
Partners Daniel de Miranda Facó and Eliana Chimenti, and associates Alessandra
de Souza Pinto, Daniel Cais Pavani Silva Gomes, Karina Cardozo de Oliveira and
Marcella Toniolo Tasca
(Latin Lawyer 27.07.2012)
(Notícia na Íntegra)